Biogen will stop selling its controversial Alzheimer’s drug Aduhelm | News
Biogen will cease promoting its Alzheimer’s therapy Aduhelm, a drug as soon as seen as a possible blockbuster that stumbled ...
Tag: Biogen
Eisai, Biogen get FDA approval for Alzheimer’s drug
The U.S. Meals and Drug Administration on Friday permitted the Alzheimer's drug lecanemab developed by Eisai Co Ltd and Biogen ...
New Alzheimer’s drug from Biogen and Eisai is just the beginning
A drug developed by Biogen Inc. and Eisai Co. has achieved a primary in Alzheimer’s analysis: In a big, late-stage ...
South Korea: Samsung Biologics completes Biogen stake in Samsung Bioepis
Korea-listed absolutely built-in CDMO, Samsung Biologics, has accomplished the acquisition of Biogen’s stake within the Samsung Bioepis three way partnership ...